Hot News : U.S. Bancorp (NYSE:USB), Celgene Corporation (NASDAQ:CELG), Education Management Corporation (NASDAQ:EDMC), FleetCor Technologies, Inc. (NYSE:FLT), Novartis AG (NYSE:NVS)

On Oct 22, U.S. Bancorp (NYSE:USB) reported a slight increase in third-quarter profit as its revenue rose and it posted loan growth. The results were in line with analysts’ expectations. The Minneapolis-based bank said it earned a little more than $1.47 billion in the quarter, up from just under $1.47 billion a year earlier. On a per-share basis, the bank earned 78 cents, up from … Continue reading Hot News : U.S. Bancorp (NYSE:USB), Celgene Corporation (NASDAQ:CELG), Education Management Corporation (NASDAQ:EDMC), FleetCor Technologies, Inc. (NYSE:FLT), Novartis AG (NYSE:NVS)

Eye Catching Stocks : Celgene Corporation (NASDAQ:CELG), Bankrate, Inc. (NYSE:RATE), China Ming Yang Wind Power Group Limited (NYSE:MY), GILD, AxoGen, Inc. (NASDAQ:AXGN)

On Oct 20, Sequenta, Inc., announced an equity investment by Celgene Corporation (NASDAQ:CELG) and other strategic investors. This financing, in addition to funding secured from several other strategic investors, will support incorporation of the ClonoSIGHT™ minimal residual disease (MRD) test into clinical trials of medicines in development for various hematological malignancies (blood cancers) and development of new clinical diagnostics based on Sequenta’s revolutionary LymphoSIGHT™ platform. … Continue reading Eye Catching Stocks : Celgene Corporation (NASDAQ:CELG), Bankrate, Inc. (NYSE:RATE), China Ming Yang Wind Power Group Limited (NYSE:MY), GILD, AxoGen, Inc. (NASDAQ:AXGN)

Worth Watching Stocks : RF Micro Devices (NASDAQ:RFMD), Celgene (NASDAQ:CELG), RigNet, Inc. (NASDAQ:RNET), AK Steel Holding Corporation (NYSE:AKS), Power Integrations Inc. (NASDAQ:POWI)

RF Micro Devices Inc. (NASDAQ:RFMD) has been on the move lately as the stock has risen by 18.7% in the past four weeks, and it is currently trading well above its 20-Day SMA. While there can be no telling for sure, it is certainly encouraging that earnings estimates have risen in the past few weeks on the company, suggesting that sentiment on RFMD is moving in … Continue reading Worth Watching Stocks : RF Micro Devices (NASDAQ:RFMD), Celgene (NASDAQ:CELG), RigNet, Inc. (NASDAQ:RNET), AK Steel Holding Corporation (NYSE:AKS), Power Integrations Inc. (NASDAQ:POWI)

Healthcare ACtive Runners: Teva Pharmaceutical Industries (NYSE:TEVA), Exelixis (NASDAQ:EXEL), Novavax (NASDAQ:NVAX), Abbott Laboratories (NYSE:ABT), Celgene (NASDAQ:CELG)

Just a month ago, Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) snapped up portfolio company, San Mateo, CA-based Labrys Biologics, for $200 million up front and another $625 million in milestones. That deal came less than two years after Labrys was formed, and venBio partner and co-founder Corey Goodman told Xconomy at the time that venBio had contributed $8.5 million of Labrys’ $31 million Series A round plus an … Continue reading Healthcare ACtive Runners: Teva Pharmaceutical Industries (NYSE:TEVA), Exelixis (NASDAQ:EXEL), Novavax (NASDAQ:NVAX), Abbott Laboratories (NYSE:ABT), Celgene (NASDAQ:CELG)

Biotech New Highs: Celgene Corporation (NASDAQ:CELG), Omeros Corporation (NASDAQ:OMER), Repligen Corporation (NASDAQ:RGEN), Pain Therapeutics, Inc. (NASDAQ:PTIE)

Celgene Corporation (NASDAQ:CELG)’s stock had its “outperform” rating restated by Credit Suisse in a research note issued on Thursday. They currently have a $225.00 price target on the stock, up from their previous price target of $210.00. Credit Suisse’s target price would suggest a potential upside of 31.23% from the company’s current price. Celgene Corporation (NASDAQ:CELG) stock performance was 0.88% in last session and finished … Continue reading Biotech New Highs: Celgene Corporation (NASDAQ:CELG), Omeros Corporation (NASDAQ:OMER), Repligen Corporation (NASDAQ:RGEN), Pain Therapeutics, Inc. (NASDAQ:PTIE)

Biotech Active Stocks: Celgene Corporation (NASDAQ:CELG), Arena Pharmaceuticals (NASDAQ:ARNA), Cell Therapeutics (NASDAQ:CTIC), Inovio Pharmaceuticals (NYSEMKT:INO)

U.S. health regulators on Friday approved a Celgene Corporation (NASDAQ:CELG) drug to treat psoriatic arthritis, a type of arthritis associated with the skin disease psoriasis that causes joint pain, stiffness and swelling. Celgene Corporation (NASDAQ:CELG) stock performance was -3.74% in last session and finished the day at $144.40. Traded volume was 9.50million shares in the last session and the average volume of the stock remained … Continue reading Biotech Active Stocks: Celgene Corporation (NASDAQ:CELG), Arena Pharmaceuticals (NASDAQ:ARNA), Cell Therapeutics (NASDAQ:CTIC), Inovio Pharmaceuticals (NYSEMKT:INO)